ABPM Executive Director, Christopher J. Ondrula, JD, joined ABPM’s Sub-Board Director, Michael Weaver, MD, FASAM, and President-Elect of the American College of Academic Addiction Medicine (ACAAM) and ABPM Addiction Medicine Diplomate, Martha Wunsch, MD, FAAP, FASAM, along with stakeholders from across the United States at an Office of National Drug Control Policy session on “Building the Addiction Medicine Workforce: Giving Americans Access to the Care They Need” on June 25, 2019 in Washington, D.C.

“We are very pleased with the attention this incredibly important issue is receiving,” said Dr. Weaver, “and we are very encouraged that the momentum from this meeting continues in the discussions we have had and will continue to have with others who are committed to moving forward towards achieving an adequate physician workforce to confront the current opioid crisis.”

Read more about this important development in the ongoing fight against opioid addiction.